We keep our
finger on the
pulse of the
Our experts are publishing articles and supporting companies that are working with health solutions to help solve the global pandemic.
Our clients and experts are involved in COVID-19 projects across the globe.
In clinical trials
BeyondAir’s ongoing research about the use of nitric oxide in treatments for several respiratory conditions, including COVID-19, using their LungFit™ systems has been continuously generating useful data. Recently BeyondAir has announced that the first patient enrolled in their U.S. study of Nitric Oxide Therapy Using the LungFit™ System for a possible COVID-19 treatment. Health Canada has also approved a study for the use of LungFit™ system in COVID-19 patients.
As part of the Canadian Super Cluster Initiative adMare Bioinnovations has partnered with Variational AI to identify existing medications, through the use of artificial intelligence, that could be repurposed for the treatment of COVID-19 patients.
Bioytical Laboratories is developing a new INSTI SARS-CoV-2 Antibody Test, which will be based on the 1-minute INSTI platform and detect antibodies to SARS-CoV-2. The project is funded by the Canadian government’s NRC IRAP.
Sanitation & Other
On the market
CSN Pharma adapted their production and are now selling handsanitizers to offer a safe return to work to their customers.
Greenfield Global has been supplying hand sanitizer and disinfectants through their distilleries and manufacturing facilities, working closely with the Canadian and US government. Furthermore, they have partnered up with Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company, to rapidly advance developments in COVID-19 detection and testing.
Available on app stores
Mimik has developed an anonymized infection tracing and positioning system as well as crisis communications and alert app, called Pandimik. The app also allows users to trace their symptoms and learn about the newest government guidelines concerning the pandemic. It is built based on Mimik’s patented hybrid edgeCloud computing platform.
XORTX’s Covid-19 program is centered around its Oxypurinol formulation, XRx-101, which they believe has the potential to serve as a frontline treatment for hospitalized COVID-19 patients due to its antiviral properties.
As a pharmaceutical knowledge base for precision medicine, electronic health records, and drug discovery, DrugBank has created a COVID-19 research overview dashboard. This dashboard provides information about drug developments, clinical trials and publications concerning COVID-19 as well as links to important government resources, COVID-19 datasets, data visualizations and research tools.